3-substituted-4-pyrimidone derivatives
A pyrimidone derivative represented by formula (I) or a salt thereof, or a solvate thereof or a hydrate thereof having inhibitory activity against tau protein kinase 1: wherein R1 represents a C1-C12 alkyl group which may be substituted; R represents, for example, a group represented by the followin...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | HIKI SHINSUKE OKUYAMA MASAHIRO OOIZUMI MITSURU WATANABE KAZUTOSHI UEHARA FUMIAKI ARITOMO KEIICHI SHODA AYA YAMAKOSHI KOICHI USUI YOSHIHIRO |
| description | A pyrimidone derivative represented by formula (I) or a salt thereof, or a solvate thereof or a hydrate thereof having inhibitory activity against tau protein kinase 1: wherein R1 represents a C1-C12 alkyl group which may be substituted; R represents, for example, a group represented by the following formula (II): wherein R2 and R3 independently represent a hydrogen atom or a C1-C8 alkyl group; R4 represents a benzene ring which may be substituted, a naphthalene ring which may be substituted, an indan ring which may be substituted, a tetrahydronaphthalene ring which may be substituted, or an optionally substituted heterocyclic ring having 1 to 4 hetero atoms selected from the group consisting of oxygen atom, sulfur atom and nitrogen atom, and having 5 to 10 ring-constituting atoms in total. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US7427615B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US7427615B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US7427615B23</originalsourceid><addsrcrecordid>eNrjZFAz1i0uTSouySwpLUlN0TXRLagsyszNTMnPS1VISS3KLEssySxLLeZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGhweYmRuZmhqZORsZEKAEAOksnkw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>3-substituted-4-pyrimidone derivatives</title><source>esp@cenet</source><creator>HIKI SHINSUKE ; OKUYAMA MASAHIRO ; OOIZUMI MITSURU ; WATANABE KAZUTOSHI ; UEHARA FUMIAKI ; ARITOMO KEIICHI ; SHODA AYA ; YAMAKOSHI KOICHI ; USUI YOSHIHIRO</creator><creatorcontrib>HIKI SHINSUKE ; OKUYAMA MASAHIRO ; OOIZUMI MITSURU ; WATANABE KAZUTOSHI ; UEHARA FUMIAKI ; ARITOMO KEIICHI ; SHODA AYA ; YAMAKOSHI KOICHI ; USUI YOSHIHIRO</creatorcontrib><description>A pyrimidone derivative represented by formula (I) or a salt thereof, or a solvate thereof or a hydrate thereof having inhibitory activity against tau protein kinase 1: wherein R1 represents a C1-C12 alkyl group which may be substituted; R represents, for example, a group represented by the following formula (II): wherein R2 and R3 independently represent a hydrogen atom or a C1-C8 alkyl group; R4 represents a benzene ring which may be substituted, a naphthalene ring which may be substituted, an indan ring which may be substituted, a tetrahydronaphthalene ring which may be substituted, or an optionally substituted heterocyclic ring having 1 to 4 hetero atoms selected from the group consisting of oxygen atom, sulfur atom and nitrogen atom, and having 5 to 10 ring-constituting atoms in total.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2008</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080923&DB=EPODOC&CC=US&NR=7427615B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080923&DB=EPODOC&CC=US&NR=7427615B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HIKI SHINSUKE</creatorcontrib><creatorcontrib>OKUYAMA MASAHIRO</creatorcontrib><creatorcontrib>OOIZUMI MITSURU</creatorcontrib><creatorcontrib>WATANABE KAZUTOSHI</creatorcontrib><creatorcontrib>UEHARA FUMIAKI</creatorcontrib><creatorcontrib>ARITOMO KEIICHI</creatorcontrib><creatorcontrib>SHODA AYA</creatorcontrib><creatorcontrib>YAMAKOSHI KOICHI</creatorcontrib><creatorcontrib>USUI YOSHIHIRO</creatorcontrib><title>3-substituted-4-pyrimidone derivatives</title><description>A pyrimidone derivative represented by formula (I) or a salt thereof, or a solvate thereof or a hydrate thereof having inhibitory activity against tau protein kinase 1: wherein R1 represents a C1-C12 alkyl group which may be substituted; R represents, for example, a group represented by the following formula (II): wherein R2 and R3 independently represent a hydrogen atom or a C1-C8 alkyl group; R4 represents a benzene ring which may be substituted, a naphthalene ring which may be substituted, an indan ring which may be substituted, a tetrahydronaphthalene ring which may be substituted, or an optionally substituted heterocyclic ring having 1 to 4 hetero atoms selected from the group consisting of oxygen atom, sulfur atom and nitrogen atom, and having 5 to 10 ring-constituting atoms in total.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2008</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFAz1i0uTSouySwpLUlN0TXRLagsyszNTMnPS1VISS3KLEssySxLLeZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGhweYmRuZmhqZORsZEKAEAOksnkw</recordid><startdate>20080923</startdate><enddate>20080923</enddate><creator>HIKI SHINSUKE</creator><creator>OKUYAMA MASAHIRO</creator><creator>OOIZUMI MITSURU</creator><creator>WATANABE KAZUTOSHI</creator><creator>UEHARA FUMIAKI</creator><creator>ARITOMO KEIICHI</creator><creator>SHODA AYA</creator><creator>YAMAKOSHI KOICHI</creator><creator>USUI YOSHIHIRO</creator><scope>EVB</scope></search><sort><creationdate>20080923</creationdate><title>3-substituted-4-pyrimidone derivatives</title><author>HIKI SHINSUKE ; OKUYAMA MASAHIRO ; OOIZUMI MITSURU ; WATANABE KAZUTOSHI ; UEHARA FUMIAKI ; ARITOMO KEIICHI ; SHODA AYA ; YAMAKOSHI KOICHI ; USUI YOSHIHIRO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US7427615B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2008</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>HIKI SHINSUKE</creatorcontrib><creatorcontrib>OKUYAMA MASAHIRO</creatorcontrib><creatorcontrib>OOIZUMI MITSURU</creatorcontrib><creatorcontrib>WATANABE KAZUTOSHI</creatorcontrib><creatorcontrib>UEHARA FUMIAKI</creatorcontrib><creatorcontrib>ARITOMO KEIICHI</creatorcontrib><creatorcontrib>SHODA AYA</creatorcontrib><creatorcontrib>YAMAKOSHI KOICHI</creatorcontrib><creatorcontrib>USUI YOSHIHIRO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HIKI SHINSUKE</au><au>OKUYAMA MASAHIRO</au><au>OOIZUMI MITSURU</au><au>WATANABE KAZUTOSHI</au><au>UEHARA FUMIAKI</au><au>ARITOMO KEIICHI</au><au>SHODA AYA</au><au>YAMAKOSHI KOICHI</au><au>USUI YOSHIHIRO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>3-substituted-4-pyrimidone derivatives</title><date>2008-09-23</date><risdate>2008</risdate><abstract>A pyrimidone derivative represented by formula (I) or a salt thereof, or a solvate thereof or a hydrate thereof having inhibitory activity against tau protein kinase 1: wherein R1 represents a C1-C12 alkyl group which may be substituted; R represents, for example, a group represented by the following formula (II): wherein R2 and R3 independently represent a hydrogen atom or a C1-C8 alkyl group; R4 represents a benzene ring which may be substituted, a naphthalene ring which may be substituted, an indan ring which may be substituted, a tetrahydronaphthalene ring which may be substituted, or an optionally substituted heterocyclic ring having 1 to 4 hetero atoms selected from the group consisting of oxygen atom, sulfur atom and nitrogen atom, and having 5 to 10 ring-constituting atoms in total.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US7427615B2 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | 3-substituted-4-pyrimidone derivatives |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T20%3A33%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HIKI%20SHINSUKE&rft.date=2008-09-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS7427615B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |